In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $36.17, marking a -5.51% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.45%. Elsewhere, the Dow lost 0.25%, while the tech-heavy Nasdaq lost 1.16%.
Prior to today's trading, shares of the company had gained 40.89% outpaced the Medical sector's gain of 6.33% and the S&P 500's gain of 2.14%.
Analysts and investors alike will be keeping a close eye on the performance of Hims & Hers Health, Inc. in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of -$0.07, marking a 141.18% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $690.21 million, up 26.68% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.27 per share and a revenue of $2.91 billion, signifying shifts of -150.94% and +23.78%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Hims & Hers Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 49.21% downward. Hims & Hers Health, Inc. currently has a Zacks Rank of #5 (Strong Sell).
In the context of valuation, Hims & Hers Health, Inc. is at present trading with a Forward P/E ratio of 1435.5. This valuation marks a premium compared to its industry average Forward P/E of 28.26.
Investors should also note that HIMS has a PEG ratio of 107.73 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry had an average PEG ratio of 3.21 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 161, this industry ranks in the bottom 35% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).